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ASBTRACT 
Objective:  Determine the frequency of elevated mean platelet volume in patients with different severities of acute 
ischemic stroke who presented in Lahore general hospital Lahore. 
Study Design:  Cross sectional survey. 
Duration:  Study duration was 1year. 
Sample Size:  130 patients of acute ischemic stroke. 
Sample Technique:  Non-probability purposive sampling. 
Methodology:  Consecutive 130 patients of acute ischemic stroke presented to emergency department or admitted 
through OPD within 24 hours of onset of symptoms and fulfilling the inclusion criteria were selected. Patients 
were divided in two groups based on mRS scoring. MPV was measured by automated hematology analyser 
Sysmex KX-21. The severity of stroke was assessed by Modified Rankin Score (mRS) between 24 to 72 hours of 
onset of symptoms.Patients with acute ischemic stroke proved by CT brain presenting within 24 hours of symptom 
onset and Age 40 and above and both genders were include. Patients with hematological malignancies were 
excluded from study. 
Data Collection:  130 patients admitted patients (through emergency and outdoor), Lahore General Hospital, 
Lahore fulfilling the inclusion criteria were selected for study.The severity of stroke was assessed by modified 
Rankin Scoring (mRS). The patients were divided in to two groups based on mRS scoring. Mean platelet volume 
and mRS score were recorded. Major risk factors like hypertension, diabetes mellitus, smoking history and 
hypercholesterolemia if present were also recorded. The demographic information of these cases like name, age, 
sex and address recorded. The collected information was entered into SPSS version 11.0. Quantitative variables 
like age, mean platelet volume were analyzed as mean and standard deviation. Frequencies of elevated MPV in 
both groups were described. Gender and severity of stroke (mild, moderate to severe) were analysed as frequency 
and percentage. Elevated MPV was also analysed as frequency and percentage in both groups 
Results  Among the enrolled 130 patients 80 (61.5%) were males and 50 (38.5%) were females (Table 1, Graph 
1) with age ranging from 41 – 74 years with a mean age of 56.85 ± 10.15 years. 45 (35%) patients had modified 
Rankin scale (mRS) between 0 to 2 while 85 (65%) patients had mRS between 3 to 6. Overall mean platelet 
volume was found to be elevated in 85 patients. Among them 62 (73%) patients had mRS of 3 – 6 (group 2) while 
23 patients had mRS of 0 – 2 (group 1). Among the 45 (23%) patients who had normal mean platelet volume, 22 
belonged to group 1 (mRS 0 – 2) while 23 were in group 2 (mRS 3 – 6). 
Conclusion:  MPV, with an easy way of measurement, may be anearly and important predictor for the prognosis 
of ischemic stroke. 
Key Words:  Stroke, Modified Rankin Score, Mean Platelet volume. 
Abbreviations:  mRS: Modified Rankin scale. CBF: Cerebral blood flow. DALYs: Disability-adjusted life years. 
MPV: Mean Platelet Volume. 
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INTRODUCTION 
Stroke is a common medical emergency with an ann-
ual incidence of between 180 and 300 per 100,000.
1
 In 
Pakistan ischemic stroke is more common, nearly 80% 
of the stroke cases.
2
 The brain receives its blood sup-
ply from the internal carotid arteries (anterior circulat-
ion) and vertebrobasilar system. The four arteries lie 
within the sub-arachnoid space. In general, branches 
derived from the vertebral arteries supply the caudal 
half of the brain, including the brainstem, midbrain, 
and most of the thalamus, while branches of the inter-
nal carotid arteries supply basal ganglia, frontal and 
parietal lobes, the lateral portions of the temporal lob-
es, and most of the internal capsule.
3
 The average of 
cerebral blood flow (CBF) in young adults is 50 – 65 
ml / 100 grams of brain / min. For the entire brain, this 
amounts to a total of 750 – 900 ml / min, or 15% of the 
cardiac output. 
 Stroke is rapidly developing clinical signs of focal 
(at times global) disturbance of cerebral function, las-
ting for more than 24 hours or leading to death, with 
no apparent cause other than of vascular origin
1. 
It is 
the leading cause of adult disability in the United Sta-
tes and Europe and it is the second leading cause of 
death worldwide.
1
 In Western countries, about 80% of 
strokes are caused by focal cerebral ischemia due to 
arterial occlusion, and the remaining 20% are caused 
by hemorrhages.
4,5
 
 Stroke accounts for about 10% of all deaths in 
most industrialized countries and most of these deaths 
are among persons over the age of 65. About one – 
fifth of patients with an acute stroke die within one 
month of the event, and at least half of those who sur-
vive are left with a physical disability.
1
 
 Mortality in the first month after stroke has been 
reported to range from 2.5% in patients with multiple 
lacunar infarcts to 78% in patients with space – occu-
pying hemispheric infarction.
20
 Stroke causes over 5.5 
million deaths annually and two third of these occur in 
the developing world. Among the stroke subtypes, 
ischemic stroke is more common, nearly 80% of all 
strokes are of this variety in developing countries.
2
 In 
the last decade, according to the American Heart Asso-
ciation the mortality rate from stroke has declined by 
12%, but the total number of strokes may again be 
rising.
6
 Cerebrovascular disease was also the fifth lea-
ding cause of lost productivity, as measured by disabi-
lity – adjusted life years (DALYs). DALYs include 
years of productivity lost to either death or varying 
degrees of disability. In 1990, cerebrovascular disease 
caused 38.5 million DALYs throughout the world.
21
 
Modifiable risk factors for stroke include hypertens-
ion, cardiac diseases (particularly atrial fibrillation), 
diabetes, hyperlipidaemia, smoking and transient isch-
emic attack.
2
 In last few years MPV is arousing increa-
sing interest as a new independent cardiovascular risk 
factor.
7
 High mean platelet volume has been shown to 
be associated with coronary atherosclerosis, acute 
coronary syndrome and myocardial infarction.
7,8
 A 
considerable body of experimental evidence docume-
nts a role of increased platelet reactivity in the deve-
lopment of various ischemic stroke types and it is con-
sidered to be a relevant pathophysiological factor in 
approximately 50% of all strokes
9
. In the last decade, 
according to the American Heart Association the mor-
tality rate from stroke has declined by 12%, but the 
total number of strokes may again be rising.
6
 
 The rationale of the study is to help attending phy-
sicians to know about the possible risks of increased 
platelet volume on stroke severityand such patients can 
be given more vigilant and aggressive care that can in-
turn lead to reduction in morbidity/mortality. 
 
METHODOLOGY 
It was a cross sectional study with non probability 
purposive sampling technique conducted in Lahore 
general hospital Lahore from July 2014 to July 2015. 
All consecutive 130 patients of acute ischemic stroke 
who fulfilled the inclusion criteria were included in the 
study. All Patients with acute ischemic stroke proved 
by CT brain presenting within 24 hours of symptom 
onset and age 40 and above and both genders were 
included in the study. 
 Patients with hematological malignancies assessed 
on blood count and blood smear and patients with 
abnormally high numbers on blood counts and patients 
showing atypical cells on blood smear were excluded 
from study. 
 The severity of stroke was assessed by modified 
Rankin Scoring (mRS). The patients were divided in to 
two groups based on mRS scoring. Patients in group 1 
had mRS score 0 to2 (no or only mild neurological 
symptoms) and patients in group 2 had mRS score 3 to 
6 (moderate or severe disability / death). 3 cc of ven-
ous blood for mean platelet volume was collected in 
CBC vacuum tube and was sent to Hematology Labo-
ratory, where MPV was measured by automated hema-
tology analyser Sysmex KX-21. Mean platelet volume 
and mRS score were recorded. Major risk factors like 
hypertension, diabetes mellitus, smoking history and 
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hypercholesterolemia if present were also recorded.  
Confounding variables like age of patients, sex, and 
history of smoking, diabetes, hypertension, hypercho-
lesterolemia and any heart disease were controlled 
through matching of patients. The demographic infor-
mation of these cases like name, age, sex and address 
recorded. Informed consent was taken before including 
patients in the study.The collected information was 
entered into SPSS version 11.0. Quantitative variables 
like age, mean platelet volume were analyzed as mean 
and standard deviation. Frequency of elevated MPV in 
both groups was described. Gender and severity of str-
oke (mild, moderate to severe) were analyzed as frequ-
ency and percentage. Elevated MPV were also analy-
zed as frequency and percentage in both groups. 
 
RESULTS 
Among the enrolled 130 patients 80 (61.5%) were 
males and 50 (38.5%) were females with age ranging 
from 41 – 7 years with a mean age of 56.85 ± 10.15 
years. Among the different age groups 32 (25%) were 
in between 40 – 50 years, 78 (60%) were in between 
51 – 60 years and 20 (15%) were in between 61 – 70 
years of age. 
 Among 130 patients, 45 (35%) patients had modi- 
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Fig. 1: 
 
Table 1: Distribution of cases based on severity of 
stroke. 
 
mRS Number Percentage 
0 – 2 (Group – 1)   45   35.0 
3 – 6 (Group – 2)   85   65.0 
Total 130 100.0 
fied Rankin scale (mRS) between 0 to 2 while 85 
(65%) patients had mRS between 3 to 6. Patients hav-
ing modified Rankin scale (mRS) 0 to 2 were included 
in group 1(mild stroke) while patients having modified 
Rankin scale (mRS) 3 to 6 were included in group 2 
(moderate / severe stroke). 
 
Table 2: Frequency of normal and elevated MPV in 
group 1. 
 
Gender 
Mean Platelet volume 
Total 
Normal Elevated 
Male  12 (54.5%) 12 (52%) 24 
Female  10 (46.5%) 11 (48%) 21 
Total  22 23 45 
 
Table 3: Frequency of normal and elevated MPV in 
group 2. 
 
Gender 
Mean Platelet volume 
Total 
Normal Elevated 
Male 14 (60.8%) 42 (67.7%) 56 
Female 9 (39.2%) 20 (32.3%) 29 
Total 23 62 85 
 
Table 4: Overall frequency of normal and elevated 
MPV in both groups. 
 
mRS 
Mean Platelet volume 
Total 
Normal Elevated 
0 – 2 22 (49%) 23 (51%)   45 
3 – 6 23(27%) 62 (73%)   85 
Total 45 85 130 
 
 In Group 1, out of total 45 patients, 24 (53.4%) 
were males and 21 (46.6%) were females. Mean pla-
telet volume was found to be elevated in 23 patients 
(51%) where as remaining 22 (49%) patients had mean 
platelet volume with in normal range. Among the 23 
patients who had elevated mean platelet volume, 12 
(52%) were male while 11 (48%) were females (Table 
5). 
 Group 2 included 85 patients who had modified 
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Table 5: Distribution of cases by neurologic impair-
ment. 
 
mRS Male Female Total 
1 10 8 18 (13.8%) 
2 14 13 27 (20.7%) 
3 16 7 23 (17.7%) 
4 31 17 48 (37%) 
5 9 5 14 (10.7%) 
Total 80 50 130 (100%) 
 
Rankin scoring (mRS) 3 to 6. Out of these 56 (65.8%) 
were males and 29 (34.2%) were females. Mean plate-
let volume was found to be elevated in 62 (73%) pati-
ents while it was with in normal limits in 23 (27%) 
patients. Among 62 patients who had elevated mean 
platelet volume, 42 (67.7%) were males and 20 
(32.3%) were females. Among 23 patients who had 
normal mean platelet volume, 14 (60.8%) were males 
while 9 (39.3%) were females. 
 Out of total 130 patients, 85 (65%) patients had 
elevated mean platelet volume. Out of them 54 
(63.5%) were males while females patients were 31 
(36.5%). Mean platelet volume was not raised in 45 
(35%) patients. Among them, 26 (57.8%) were males 
and 19 (42.2%) were females. 
 Overall mean platelet volume was found to be 
elevated in 85 patients. Among them 62 (73%) patients 
had mRS of 3 – 6 (group 2) while 23 patients had mRS 
of 0 – 2 (group 1). Among the 45 (23%) patients who 
had normal mean platelet volume, 22 belonged to 
group 1 (mRS 0 – 2) while 23 were in group 2 (mRS 
3 – 6). 
 Patients had spectrum of neurological deficit rang-
ing from no significant disability to severe disability 
resulting in immobility and limitation to bed. As men-
tioned previously, modified Rankin scale (mRS) was 
used to describe the disability of patient. Among all 
the patients, 18 (13.8%) patients had no significant 
disability despite symptoms and were able to carry out 
all usual activities and hence had modified Rankin 
scale (mRS) of 1. Patients falling under this category 
included 10 (55.5%) males and 8 (44.4%) females. 27 
(20.7%) patients had slight disability; unable to carry 
out all previous activities, but able to look after own 
affairs without assistance and hence had modified 
Rankin scale (mRS) of 2. This group included 14 
(51.8%) males and 13 (48.1%) females. Patients hav-
ing moderate disability; requiring some help, but able 
to walk without assistance (modified Rankin scale 
(mRS) of 3) constituted 17.7% (23 patients) of pro-
portion. Among them male patients were 16 (69.5%) 
and female patients were 7 (30.4). Patients who had 
moderately severe disability; unable to walk without 
assistance and unable to attend to own bodily needs 
without assistance (modified Rankin scale (mRS) of 4) 
were 48 (37%), 31 (64.5%) males and 17 (35.4%) 
females fell into this category. Patients who had severe 
disability; bedridden, incontinent and required con-
stant nursing care and attention were included in modi-
fied Rankin scale (mRS) of 5, 14 (10.7%) patients had 
neurological dysfunction to this extent and patients 
included 9 (64.2%) males and 5 (35.7%) females. 
 
DISCUSSION 
Stroke is the third most common cause of death in the 
developed world after cancer and ischemic heart dise-
ase, and is the most common cause of severe physical 
disability.
1
 Many of the patients are left with variable 
degree of permanent neurological impairment. Stroke 
causes over 5.5 million deaths annually and two third 
of these occur in the developing world. Among the 
stroke subtypes, ischemic stroke is more common, 
nearly 80% of all strokes are of this variety in deve-
loping countries.
2
 
 Epidemiological investigations of the manner in 
which strokes arise and evolve have begun to identify 
highly vulnerable persons and the factors which pre-
dispose. Estimates of the risk associated with identi-
fied stroke precursors, singly and in combination, have 
been ascertained.
10
 
 Mean Platelet Volume (MPV) is a measurement of 
the average size of platelets found in blood and is typi-
cally included in routine blood tests.
11
 MPV is a mar-
ker of platelets’ function and is positively associated 
with indicators of platelet activity, including aggregat-
ion and release of thromboxane A2, platelet factor 4 
and B thromboglobulin.
12
 Elevated mean platelet 
volume (MPV) is associated with a shortened bleeding 
time.
7
 Large platelets contain more dense granules and 
produce large amounts of thromboxane A2.
13
 Larger 
platelets are enzymatically and metabolically more 
active and have a higher potential thrombotic ability as 
compared with smaller platelets.
14
 The release of large 
and more reactive platelets may contribute to the thro-
mbophilic state associated with ischemic events.
15
 
 In last few years MPV is arousing increasing inte-
rest as a new independent cardiovascular risk factor.
7
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High mean platelet volume has been shown to be asso-
ciated with coronary atherosclerosis, acute coronary 
syndrome and myocardial infarction.
7,8
 A considerable 
body of experimental evidence documents a role of 
increased platelet reactivity in the development of 
various ischemic stroke types and it is considered to be 
a relevant pathophysiological factor in approximately 
50% of all strokes.
9
 
 A study conducted by Greisenegger, Endler and 
their colleagues to observe the affect of elevated MPV 
on outcome of acute ischemic stroke showed that Pati-
ents within the highest quintile of MPV had a signifi-
cantly higher risk of suffering a severe stroke, defined 
as modified Rankin Scale score of 3 to 6, compared 
with patients within the lowest quintile (odds ratio = 
2.6; 95% confidence interval, 1.6 to 4.1; P < 0.001). 
This association remained significant after adjustment 
for possible confounding factors (odds ratio = 2.2; 
95% confidence interval, 1.2 to 4.0; P = 0.013).
16
 
 In 2008, Slaven Pikija, Danijel Cvetko, Martina 
Hajduk, Vladimir Trkulja conducted a study on 81 
consecutive patients of acute ischemic stroke patients 
in attempt to find an association between elevated 
mean platelet volume with larger infarct volume on 
CT brain scans and with worse clinical outcome. They 
showed that higher mean platelet volume was indepen-
dently associated with larger infarct volume [estimate 
0.259, 95% confidence interval (CI) 0.004 –0.513, P = 
0.046], greater risk of death/dependence 7 days post-
stroke [relativerisk (RR) = 1.077, 95% CI 1.005 – 
1.115, P = 0.036], and greater risk of death / depen-
dence 3 months post-stroke (RR = 1.077, 95% CI 
1.001 – 1.158, P = 0.048)9. 
 In 2010, Mayda-Domaç F, Misirli H, Yilmaz M. 
conducted study on 692 patients with either ischemic 
or hemorrhagic stroke and compared them with 208 
control subjects withsimilar risk factors, but without 
evidence of vascular events. The association of MPV 
and PC with cause, localization, and size of the infarct 
or hemorrhage was examined. Prognosis was deter-
mined by Glasgow Outcome Scale. They found out 
that mean platelet volumeis independent risk factor for 
ischemic stroke (P 5.007, odds ratio [OR] 5 0.866; P 
5.000, 95%confidence interval). Ischemic group MPV 
(P 5 .013, OR 5 1.02, 95% CI) was in correlation with 
worse outcome (P 5.001, OR 5 1.004, 95% CI).
17
 
 Up till now, we do not have any local study in 
Pakistan that is attempted to find any association of 
elevated mean platelet volume with stroke severity/ 
prognosis. Our study was designed to determine and 
categorize the severity of acute ischemic stroke pre-
senting in a tertiary care hospital and to determine 
frequency of elevated mean platelet volume in patients 
with different severities of acute ischemic stroke. 
 My study was conducted at Lahore General Hos-
pital, Lahore over a period of 6 months. 130 patients 
of acute ischemic stroke fulfilling the inclusion criteria 
were included in the study. There were 80 (61.5%) 
males and 50 (38.5%) females in our study with male 
to female ratio of 1.6:1. There was male predominance 
in our study which is similar to studies done by Geo-
rge Ntaios and his colleagues
19
 (Male 57.7%, Female 
42.3%) and Greisenegger S. and his colleagues
16
 
(Male 55%, Female 45%). However studies done by 
Slaven Pikija and his colleagues
9
 (Males 39.5%, Fem-
ales 60.5%) and Mayda – Domaç F and colleagues17 
(Males 49%, Females 51%) reported female predomi-
nance in patients presenting with acute ischemic stro-
ke. Mean age in our study was 56.85 ± 10.15 years 
which is less than studies done by Mayda-Domaç F 
and colleagues
17
 (65.16 ± 12.6), George Ntaios and his 
colleagues (73 ± 15.8).
18.
 
 The results of my study showed that the majority 
i.e. 65% of patients had moderate to severe (mRS 3 to 
6) acute ischemic stroke while 45% patients had mild 
(mRS 0 to 2) acute ischemic stroke. These findings are 
similar to those of Slaven Pikija, Danijel Cvetko, 
Martina Hajduk, Vladimir Trkulja.
9
 Their study also 
showed that patients presenting with moderate to sev-
ere stroke (66.7%) outnumbered the patients present-
ing with mild stroke. Similarly study by George Ntaios 
and his colleagues also had majority (57%) of patients 
presenting with severe stroke.
19
 However study by 
Greisenegger, Endler and their colleagues
16
 showed 
that majority (57.6) of patients had mild stroke (mRS 0 
to 2). 
 Mean platelet volume was found to be elevated in 
51% of patients having mild stroke (mRS 0 to 2) whe-
re as it was elevated in 73% patients having moderate 
to severe stroke (mRS 3 to 6). These findings show 
that higher MPV was associated with higher risk of 
dependence/death i.e. mRS score 3 to 6 (P = 0.039). 
These findings again corroborate those of Greisene-
gger S and his colleagues. Their study showed that 
mean platelet volume was elevated in 57% of patients 
having mild stroke while mean platelet volume was 
found to be elevated in 67% of patients having mode-
rate / severe stroke.
16
 
 Majority of currently available studies report posi-
tive correlation between MPV and stroke out-
come.
9,16,17
 
 We described a relation between MPV and clinical
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severity of acute ischemic cerebrovascular events. 
Measurementof MPV is easy to establish and therefore 
might serve as a valuablepredictor of a worse outcome 
in patients with acute ischemic cerebrovascular events. 
 
CONCLUSION 
In conclusion, our study agrees with the clinical impo-
rtance of MPV in ischemic stroke. Platelet volume 
indices that are done routinely may be helpful in pre-
dicting the outcome of acute ischemic stroke. Our data 
support the view that MPV is a determinant of stroke 
severity / outcome. MPV, with an easy way of measu-
rement, may be anearly and important predictor for the 
prognosis of ischemicstroke. Thus the study of MPV 
might act as additional tool to identify people at high 
risk and such patients can be given more vigilant and 
aggressive care that can in-turn lead to reduction in 
morbidity/mortality. 
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